Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
It can increase the body's ability to fight infection and disease
GLP-1s illustrate this well: injectables lead today because they deliver better clinical outcomes, while continued oral innovation reflects market expansion and access potential for a larger patient population. Groups continue to innovate the ways in which peptide- and protein-based biologics (including GLP-1 medications) are administered
(2014) 100(Suppl 1):496S502S
As they can react with the chemotherapy drug and change the treatment outcomes
Future directions include the design and synthesis of novel compounds that can mitigate these side effects while maintaining or enhancing efficacy
